Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Horst

Showing results (211-220 of 221) with videos related to

Pageof 23
Sort By:
Cancers|July 14, 2023
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical ValidationEva-Maria Willing, Claudia Vollbrecht, Christine Vössing, et al.
Cancer Communications (London, England)|March 15, 2025
Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature geneFlorian Henning Geyer, Alina Ritter, Seneca Kinn-Gurzo, et al.
Ebiomedicine|August 5, 2022
Assessing and improving the validity of COVID-19 autopsy studies - A multicentre approach to establish essential standards for immunohistochemical and ultrastructural analysesSusanne Krasemann, Carsten Dittmayer, Saskia von Stillfried, et al.
Nature Communications|July 25, 2022
Therapeutic targeting of ATR in alveolar rhabdomyosarcomaHeathcliff Dorado García, Fabian Pusch, Yi Bei, et al.
The Journal of Clinical Investigation|June 1, 2023
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune responseMihnea P Dragomir, Enrique Fuentes-Mattei, Melanie Winkle, et al.
Nature Neuroscience|December 1, 2020
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, et al.
Nature Neuroscience|February 17, 2024
Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19Josefine Radke, Jenny Meinhardt, Tom Aschman, et al.
Virchows Archiv : an International Journal of Pathology|April 2, 2022
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Danny Jonigk, Christopher Werlein, Till Acker, et al.
The European Respiratory Journal|June 21, 2022
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophagesKatja Hönzke, Benedikt Obermayer, Christin Mache, et al.
Cell|December 16, 2021
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosisDaniel Wendisch, Oliver Dietrich, Tommaso Mari, et al.
Pageof 23

Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Cancers|July 14, 2023
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical ValidationEva-Maria Willing, Claudia Vollbrecht, Christine Vössing, et al.
Cancer Communications (London, England)|March 15, 2025
Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature geneFlorian Henning Geyer, Alina Ritter, Seneca Kinn-Gurzo, et al.
Ebiomedicine|August 5, 2022
Assessing and improving the validity of COVID-19 autopsy studies - A multicentre approach to establish essential standards for immunohistochemical and ultrastructural analysesSusanne Krasemann, Carsten Dittmayer, Saskia von Stillfried, et al.
Nature Communications|July 25, 2022
Therapeutic targeting of ATR in alveolar rhabdomyosarcomaHeathcliff Dorado García, Fabian Pusch, Yi Bei, et al.
The Journal of Clinical Investigation|June 1, 2023
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune responseMihnea P Dragomir, Enrique Fuentes-Mattei, Melanie Winkle, et al.
Nature Neuroscience|December 1, 2020
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, et al.
Nature Neuroscience|February 17, 2024
Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19Josefine Radke, Jenny Meinhardt, Tom Aschman, et al.
Virchows Archiv : an International Journal of Pathology|April 2, 2022
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Danny Jonigk, Christopher Werlein, Till Acker, et al.
The European Respiratory Journal|June 21, 2022
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophagesKatja Hönzke, Benedikt Obermayer, Christin Mache, et al.
Cell|December 16, 2021
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosisDaniel Wendisch, Oliver Dietrich, Tommaso Mari, et al.
Pageof 23